Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Acta cir. bras ; 33(8): 664-672, Aug. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-949374

RESUMEN

Abstract Purpose: To investigate the correlation of inhaled nitric oxide (NO) on plasma levels of cardiac troponin I (cTnI) and von Willebrand factor (vWF), glycoprotein (GP) IIb/IIIa, granule membrane protein 140 (GMP-140) in rabbits with acute massive pulmonary embolism (PE). Methods: Thirty apanese white rabbits were divided into 3 groups, thrombus were injected in model group (n = 10), NO were inhalated for 24 h after massive PE in NO group (n = 10), saline were injected in control group (n = 10). The concentrations of vWF, GP IIb/IIIa, GMP-140 and cTnI were tested at 4, 8, 12, 16, 20, and 24 h, Correlation analyses were conducted between cTnI and vWF, GP IIb/IIIa, and GMP-140 by Pearson's correlation. Results: The concentration of cTnI and vWF, GP IIb/IIIa, and GMP-140 was increased in the model group, compared to control group. In the inhaled group, the concentrations of cTnI, vWF, GP IIb/IIIa, and GMP-140 were reduced compared to model group. There was a positive correlation between cTnI and vWF, GP IIb/IIIa, and GMP-140. Conclusion: Inhaled nitric oxide can lead to a decrease in levels of cardiac troponin I, von Willebrand factor, glycoprotein, and granule membrane protein 140, after an established myocardial damage, provoked by acute massive pulmonary embolism.


Asunto(s)
Animales , Conejos , Embolia Pulmonar/sangre , Factor de von Willebrand/análisis , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/análisis , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/efectos de los fármacos , Selectina-P/sangre , Troponina I/sangre , Óxido Nítrico/administración & dosificación , Embolia Pulmonar/patología , Embolia Pulmonar/tratamiento farmacológico , Valores de Referencia , Factores de Tiempo , Administración por Inhalación , Factor de von Willebrand/efectos de los fármacos , Reproducibilidad de los Resultados , Resultado del Tratamiento , Selectina-P/efectos de los fármacos , Troponina I/efectos de los fármacos , Modelos Animales de Enfermedad , Microtomografía por Rayos X , Ventrículos Cardíacos/patología , Miocardio/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA